-
Most Recent
Search Results
240 results for MSO
The Fed Won’t Turn Dovish – So, Here’s the Play
Why Wall Street misread Friday’s jobs report… the data weren’t dovish, they were messy… the Fed is due for a pause, not a pivot… the…
Why Wall Street Is Watching October So Closely This Year
Midterm years often bring market volatility, and Louis Navellier and Marc Chaikin see an unusual setup forming ahead of Election Day.
The Copper Treasure Hunt: 3 Ways to Look for a Payoff
Pretty regularly here, I go over why I believe Freeport-McMoRan could benefit from the AI buildout, and why its efforts to produce more copper make…
AI Stocks Just Hit a Speed Bump, so Here’s Where Luke Is Looking Next
In this Friday Digest takeover, our technology expert, Luke Lango, makes an important distinction. Building tomorrow’s AI is only one side of the boom. The…
MSO Is Crap, New CEO Unlikely to Help
Martha Stewart Living hired Daniel Dienst as its CEO. But even with his reputation as a fixer, Dienst is going to have a tough time…
5 Stocks With Bad Analyst Earnings Revisions — GLYC AMCC SOL MSO IFT
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Awful Analyst Earnings Revisions — GLYC AMCC SOL MSO IFT
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Analyst Earnings Revisions — AMCC PKT ISH MSO IFT
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Analyst Earnings Revisions — GLYC AMCC SOL MSO IFT
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Analyst Earnings Revisions — AMCC PKT ISH MSO IFT
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
Why Is Avalon GloboCare (ALBT) Stock Up 173% Today?
Avalon GloboCare stock is up on Wednesday as ALBT investors react to a new product launch from Laboratory Services MSO.
Does Anyone Win in the Martha Stewart Trial?
The retail trial of the century pits Macy’s against Martha Stewart and JCPenney. Who will come out on top in this three-ring circus? Let’s take…
4 Media Stocks to Sell Now
This week, the overall grades of four Media stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
3 Media Stocks to Sell Now
This week, the ratings of three Media stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Martha Stewart Makes Waves — Wednesday’s IP Market Recap
Martha Stewart Living Omnivision shares soar Wednesday on news that J.C. Penney plans to buy a 16.6% bid in the company and offer its products…
M, JCP: Macy’s Wins Martha Stewart Case Against JC Penney’s
A N.Y. Supreme Court judge ruled that JCPenney (JCP) did infringe on Macy’s (M) deal with Martha Stewart, but won’t face punitive damages.
Macy’s Hauls Martha Stewart Into Court
Martha Stewart Living Omnimedia’s new deal with J.C. Penney has Macy’s in a litigious dither, claiming a violation of its own agreement with Stewart.
Analyst’s Top 3 Cannabis Stocks Are Not What You Think
While publicly-listed U.S. cannabis stocks are getting all the attention, MSOs CURL, MMNFF and GTBIF may offer investors the most upside.
5 CEOs Who Might Not Last Until 2015
Chief executives don’t actually have a long shelf life on average, but these five CEOs might be out quicker than most.
J.C. Penney to Cut Thousands of Jobs
A New York Post report says the struggling retailer will cut thousands of jobs, hitting most of the retailer’s 1,200 locations.
5 Stocks That Are Toxic Takeover Targets
Here’s why no CEO in his right mind would buy any of these brands.
7 Cannabis Stocks to Sell in July Before They Crash & Burn
With marijuana still facing legalization limbo, it’s high time to bail on these seven cannabis stocks to sell.
1 – 10 of 240 results